GF15 is a potent inhibitor of centrosomal clustering, inducing multipolar mitosis with an EC50 of 900 nM; it exhibits concentration-dependent cytotoxicity against a broad spectrum of tumor cell lines, including those derived from colon, cervix, glioblastoma, pancreas, leukemia, and myeloma, with IC50 values of 1–5 μM; in vivo, GF15 inhibits tumor growth and significantly prolongs survival in mouse xenograft models of human colon cancer and multiple myeloma.